SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(5.10%),Steven Boyd(5.10%)
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WRIGHT TIMOTHY R
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Stein Robert Benjamin
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Barrage Khalil
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Buell Jennifer
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ARMEN GARO H
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Corvese Brian
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Arrow Alexander K.
Protagenic Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(5.13%),Steven Boyd(5.13%)
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Arrow Alexander K.
Protagenic Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(5.26%),Steven Boyd(5.26%)
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities
Protagenic Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(5.4%),Steven Boyd(5.4%)
Protagenic Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hudson Bay Capital Management LP(0%),Sander Gerber(0%)
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities